Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Early use of tocilizumab in solid organ transplant recipients with COVID‐19: A retrospective cohort study in Saudi Arabia

2022; Wiley; Volume: 10; Issue: 3 Linguagem: Inglês

10.1002/iid3.587

ISSN

2050-4527

Autores

Amani Yamani, Basem Alraddadi, Reem S. Almaghrabi, Afnan A. Amer, Fatimah S. Mehdawi, Mohammed A. Al-Hamzi, Meshari S. Aldajani, Majda Alattas, Aiman M. Elsaed Ramadan, Ghassan Wali, Abeer N. Alshukairi, Abbas Al Mutair,

Tópico(s)

SARS-CoV-2 and COVID-19 Research

Resumo

Tocilizumab was studied to reduce cytokine syndrome in patients with severe COVID-19 pneumonia in solid organ transplant (SOT) recipients with conflicting results. We aim to study the early use of tocilizumab in SOT with COVID-19 pneumonia on low flow oxygen.

Referência(s)